跳至主要内容
临床试验/KCT0000777
KCT0000777招募中未知

Registry and prevalence of gene mutation in Korean patients with familial hypertrophic cardiomyopathy

Korea Centers for Disease Control and Prevention0 个研究点目标入组 250 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
250

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational Study

入排标准

年龄范围
13(Year) 至 o Limit(—)
性别
All

入选标准

  • 1. Patients diagnosed as hypertrophic cardiomyopathy
  • 2. Family members of diagnosed patients
  • 3. In cases of juvenile, above age-13(yrs)
  • Patients (male or female) who is diagnosed as hypertrophic cardiomyopathy following the guidlines, were to be asked and voluntarily participated with signing the consent to participate in research
  • - Guidelines
  • a. (Adults) Without the effect of hypertrophy-causing cardiac risks (fabry disease, danon disease, glycogen storage disease, etc.), maximal wall thickness (MWT) are increased more than 15mm in left ventricle with the echocardiography result.
  • b. (in juveniles(age-13 and above)) MWT are relatively increased as adults with regard to body surface area, and not dilated.

排除标准

  • - Patients and family members who disagreed with the participation of research

研究者

发起方
Korea Centers for Disease Control and Prevention

相似试验